{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:23Z","timestamp":1786119323554,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/cji.0b013e3181a95198","type":"journal-article","created":{"date-parts":[[2009,6,18]],"date-time":"2009-06-18T03:20:06Z","timestamp":1245295206000},"page":"613-621","source":"Crossref","is-referenced-by-count":30,"title":["Melan-A\/MART1 Analog Peptide Triggers Anti-myeloma T-cells Through Crossreactivity With HM1.24"],"prefix":"10.1097","volume":"32","author":[{"given":"Olaf","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaviana","family":"Lupu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Condomines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Belle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Neuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kleist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Terness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hundemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00002371-200001000-00004","article-title":"Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma","volume":"23","author":"Kawakami","year":"2000","journal-title":"J Immunother"},{"key":"R2-8-20210208","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1084\/jem.180.1.347","article-title":"Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes","volume":"180","author":"Kawakami","year":"1994","journal-title":"J Exp Med"},{"key":"R3-8-20210208","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.4049\/jimmunol.160.4.1750","article-title":"Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A\/MART-1 immunodominant peptide analogues","volume":"160","author":"Valmori","year":"1998","journal-title":"J Immunol"},{"key":"R4-8-20210208","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1073\/pnas.242600099","article-title":"Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells","volume":"99","author":"Yee","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R5-8-20210208","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/1078-0432.CCR-05-1485","article-title":"Adoptive transfer of allogeneic cytotoxic T lymphocytes equipped with a HLA-A2 restricted MART-1 T-cell receptor: a phase I trial in metastatic melanoma","volume":"12","author":"Duval","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R6-8-20210208","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/(SICI)1097-0215(19990301)80:5<671::AID-IJC7>3.0.CO;2-E","article-title":"T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma","volume":"80","author":"Fagerberg","year":"1999","journal-title":"Int J Cancer"},{"key":"R7-8-20210208","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2002-04-1250","article-title":"T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma","volume":"101","author":"Hansson","year":"2003","journal-title":"Blood"},{"key":"R8-8-20210208","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/76243","article-title":"Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies","volume":"6","author":"Trojan","year":"2000","journal-title":"Nat Med"},{"key":"R9-8-20210208","first-page":"957","article-title":"Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma","volume":"4","author":"Wen","year":"1998","journal-title":"Clin Cancer Res"},{"key":"R10-8-20210208","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood.V94.2.673","article-title":"Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy","volume":"94","author":"Massaia","year":"1999","journal-title":"Blood"},{"key":"R11-8-20210208","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1182\/blood-2002-06-1925","article-title":"Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells","volume":"101","author":"Rasmussen","year":"2003","journal-title":"Blood"},{"key":"R12-8-20210208","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1182\/blood.V97.5.1508","article-title":"Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma","volume":"97","author":"Lim","year":"2001","journal-title":"Blood"},{"key":"R13-8-20210208","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0145-2126(00)00111-9","article-title":"MUC1 expression in plasmacytoma","volume":"25","author":"Paydas","year":"2001","journal-title":"Leuk Res"},{"key":"R14-8-20210208","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/1521-4141(200003)30:3<803::AID-IMMU803>3.0.CO;2-P","article-title":"The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells","volume":"30","author":"Pellat-Deceunynck","year":"2000","journal-title":"Eur J Immunol"},{"key":"R15-8-20210208","first-page":"1156","article-title":"Genes encoding tumor-specific antigens are expressed in human myeloma cells","volume":"94","author":"Van","year":"1999","journal-title":"Blood"},{"key":"R16-8-20210208","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.4049\/jimmunol.178.5.3307","article-title":"Cancer\/Testis genes in multiple myeloma: expression patterns and prognosis value determined by microarray analysis","volume":"178","author":"Condomines","year":"2007","journal-title":"J Immunol"},{"key":"R17-8-20210208","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.exphem.2006.01.008","article-title":"Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma","volume":"34","author":"Hundemer","year":"2006","journal-title":"Exp Hematol"},{"key":"R18-8-20210208","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1182\/blood-2002-11-3580","article-title":"Testing recombinant adeno-associated virus-gene loading of dendritic cells for generating potent cytotoxic T lymphocytes against a prototype self-antigen, multiple myeloma HM1.24","volume":"102","author":"Chiriva-Internati","year":"2003","journal-title":"Blood"},{"key":"R19-8-20210208","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2005-04-1438","article-title":"Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma","volume":"106","author":"Jalili","year":"2005","journal-title":"Blood"},{"key":"R20-8-20210208","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-04-0650","article-title":"Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24","volume":"11","author":"Rew","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R21-8-20210208","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1182\/blood.V83.12.3654.3654","article-title":"Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma","volume":"83","author":"Zhang","year":"1994","journal-title":"Blood"},{"key":"R22-8-20210208","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1038\/sj.onc.1208536","article-title":"Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells","volume":"24","author":"Mahtouk","year":"2005","journal-title":"Oncogene"},{"key":"R23-8-20210208","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/eji.1830271209","article-title":"Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions","volume":"27","author":"Jonuleit","year":"1997","journal-title":"Eur J Immunol"},{"key":"R24-8-20210208","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.4049\/jimmunol.167.10.5852","article-title":"A new generation of Melan-A\/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: implication for molecular anti-melanoma immunotherapy","volume":"167","author":"Blanchet","year":"2001","journal-title":"J Immunol"},{"key":"R25-8-20210208","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1073\/pnas.0400782101","article-title":"A gene atlas of the mouse and human protein-encoding transcriptomes","volume":"101","author":"Su","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R26-8-20210208","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/jnci\/djj358","article-title":"Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma","volume":"98","author":"Inoges","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R27-8-20210208","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.184.2.647","article-title":"Identification of epitope mimics recognized by CTL reactive to the melanoma\/melanocyte-derived peptide MART-1(27\u201335)","volume":"184","author":"Loftus","year":"1996","journal-title":"J Exp Med"},{"key":"R28-8-20210208","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.4049\/jimmunol.169.10.5696","article-title":"Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL","volume":"169","author":"Rubio-Godoy","year":"2002","journal-title":"J Immunol"},{"key":"R29-8-20210208","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.molimm.2003.11.003","article-title":"T cell receptor crossreactivity as a general property of T cell recognition","volume":"40","author":"Wucherpfennig","year":"2004","journal-title":"Mol Immunol"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CJI.0b013e3181a95198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:59:10Z","timestamp":1786039150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002371-200907000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e3181a95198","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}